Wen Bo Wang
Chief Tech/Sci/R&D Officer bei FATE THERAPEUTICS, INC.
Profil
Derzeit bekleidet Wen Bo Wang die Position des Senior Vice President-Technical Operations bei Fate Therapeutics, Inc. Dr. Wang ist außerdem Mitglied des Vorstands des Standards Coordinating Body. Zuvor hatte er die Position des Associate Scientific Director bei ViaCell, Inc. und des Senior Vice President-Cell Therapy bei FUJIFILM Cellular Dynamics, Inc. inne. Dr. Wang erhielt einen Bachelor-Abschluss von der Ocean University of China und einen Doktortitel von der Newcastle University.
Aktive Positionen von Wen Bo Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08.10.2018 |
| Standards Coordinating Body | Director/Board Member | - |
Ehemalige bekannte Positionen von Wen Bo Wang
| Unternehmen | Position | Ende |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2005 |
| CELLULAR DYNAMICS INTERNATIONAL INC | Corporate Officer/Principal | - |
Ausbildung von Wen Bo Wang
| Newcastle University | Doctorate Degree |
| Ocean University of China | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
FUJIFILM Cellular Dynamics, Inc.
 FUJIFILM Cellular Dynamics, Inc. BiotechnologyHealth Technology FUJIFILM Cellular Dynamics, Inc. engages in the provision of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. It offers cardiac cells, neural cells. hematopoietic and other, and iPSC, services and reagents. The company was founded by James A. Thomson, Igor Slukvin, Timothy J. Kamp and Craig T. January in 2004 and is headquartered in Madison, WI. | Health Technology |
| Standards Coordinating Body |
